Corticosteroid-Induced Edema
Clinical Manifestations and Monitoring
- The American College of Rheumatology recommends monitoring peripheral edema in patients receiving corticosteroid treatment, as it is a common adverse effect that needs to be managed 1, 2
- The dose and duration of corticosteroid treatment are directly related to the risk of developing edema, and monitoring should be more frequent and intensive in patients with pre-existing risk factors and those receiving high doses or prolonged treatments 1, 2
Considerations for Specific Corticosteroids
- The European Society of Medical Oncology notes that dexamethasone is preferred in some clinical situations due to its lower mineralocorticoid activity compared to other corticosteroids, although this is based on a guideline from Praxis Medical Insights, an alternative source is needed, however, the National Comprehensive Cancer Network recommends the use of corticosteroids with lower mineralocorticoid activity to reduce the risk of edema 4, 5